Levoscot Tablets 250 mg Price in Pakistan

View latest Price, manufacturer, formulation, and pack details of Levoscot Tablets 250 mg.

Available Products of Levoscot Tablets 250 mg

Levoscot Tablets 250 mg 1x10's

Reg#: 029925

Description of Levoscot Tablets 250 mg

Each Tablets contains: Levofioxacin Hemihydrate eq. To Levofloxacin 250 mg

Medicine Info

Pack Size: 1x10's

Company: Scotmann Pharmaceuticals

Price of Levoscot Tablets 250 mg

Price: Rs. 435.87

Related Keywords

  • Levoscot Tablets 250 mg price in Pakistan
  • Levoscot Tablets 250 mg tablet price
  • Levoscot Tablets 250 mg Capsule price
  • Scotmann Pharmaceuticals Levoscot Tablets 250 mg price
  • Buy Levoscot Tablets 250 mg online
  • Levoscot Tablets 250 mg uses
  • Levoscot Tablets 250 mg syrup price
  • Levoscot Tablets 250 mg pack 1x10's cost

Levoscot Tablets 250 mg 30's

Reg#: 029925

Description of Levoscot Tablets 250 mg

Each Tablets contains: Levofioxacin Hemihydrate eq. To Levofloxacin 250 mg

Medicine Info

Pack Size: 30's

Company: Scotmann Pharmaceuticals

Price of Levoscot Tablets 250 mg

Price: Rs. 1255.29

Related Keywords

  • Levoscot Tablets 250 mg price in Pakistan
  • Levoscot Tablets 250 mg tablet price
  • Levoscot Tablets 250 mg Capsule price
  • Scotmann Pharmaceuticals Levoscot Tablets 250 mg price
  • Buy Levoscot Tablets 250 mg online
  • Levoscot Tablets 250 mg uses
  • Levoscot Tablets 250 mg syrup price
  • Levoscot Tablets 250 mg pack 30's cost

Alternatives brands of Levoscot Tablets 250 mg

Explore alternative brands for Levoscot Tablets 250 mg below.

View Alternatives

Explore More Medicines

Direa-X 2mg Capsules

Scotmann Pharmaceuticals

MRP: Rs. 142.3518

Direa-X 2mg Capsules

Scotmann Pharmaceuticals

MRP: Rs. 237.2682

Voreta Plus Tablets 12.5:500 mg

Scotmann Pharmaceuticals

MRP: Rs. 369.2688

Address Tablets 5:160 mg

Scotmann Pharmaceuticals

MRP: Rs. 675.3569

Address Tablets 5:160 mg

Scotmann Pharmaceuticals

MRP: Rs. 1323.3585

We’d love to hear your thoughts!

Share your comment below and join the conversation ✨

Comments

No comments yet. Be the first!